H Garges

1.9k total citations
16 papers, 635 citations indexed

About

H Garges is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, H Garges has authored 16 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 6 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in H Garges's work include Neonatal and Maternal Infections (7 papers), Streptococcal Infections and Treatments (5 papers) and HIV/AIDS drug development and treatment (4 papers). H Garges is often cited by papers focused on Neonatal and Maternal Infections (7 papers), Streptococcal Infections and Treatments (5 papers) and HIV/AIDS drug development and treatment (4 papers). H Garges collaborates with scholars based in United States, United Kingdom and Spain. H Garges's co-authors include Daniel K. Benjamin, C. Michael Cotten, P. Brian Smith, William J. Steinbach, Reese H. Clark, M. Anthony Moody, Robert W. Lenfestey, Jennifer S. Li, Vance G. Fowler and Elizabeth R. DeLong and has published in prestigious journals such as PEDIATRICS, Journal of Antimicrobial Chemotherapy and Urology.

In The Last Decade

H Garges

15 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Garges United States 9 414 296 164 134 134 16 635
Elisabetta Tridapalli Italy 12 377 0.9× 387 1.3× 57 0.3× 156 1.2× 126 0.9× 20 742
Ioanna N. Grivea Greece 19 199 0.5× 599 2.0× 208 1.3× 68 0.5× 138 1.0× 57 887
Michael Cohen-Wolkowiez United States 14 1.0k 2.5× 761 2.6× 127 0.8× 372 2.8× 303 2.3× 18 1.4k
Donna Hensley United States 10 316 0.8× 256 0.9× 31 0.2× 101 0.8× 99 0.7× 17 599
Rimma Melamed Israel 15 199 0.5× 932 3.1× 513 3.1× 31 0.2× 104 0.8× 37 1.2k
Malgorzata A. Verboon‐Maciolek Netherlands 17 333 0.8× 650 2.2× 34 0.2× 247 1.8× 161 1.2× 20 1.1k
James K. Todd United States 9 121 0.3× 299 1.0× 134 0.8× 44 0.3× 104 0.8× 10 553
Alan E. Gober United States 20 317 0.8× 427 1.4× 116 0.7× 17 0.1× 258 1.9× 38 1.0k
Mohan Pammi Venkatesh United States 10 136 0.3× 137 0.5× 41 0.3× 47 0.4× 123 0.9× 11 468
G Vetrano Italy 9 148 0.4× 220 0.7× 37 0.2× 89 0.7× 142 1.1× 22 481

Countries citing papers authored by H Garges

Since Specialization
Citations

This map shows the geographic impact of H Garges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Garges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Garges more than expected).

Fields of papers citing papers by H Garges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Garges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Garges. The network helps show where H Garges may publish in the future.

Co-authorship network of co-authors of H Garges

This figure shows the co-authorship network connecting the top 25 collaborators of H Garges. A scholar is included among the top collaborators of H Garges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Garges. H Garges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tan, Darrell H. S., Clifford Kinder, Cornelius N. Van Dam, et al.. (2024). Weight and Metabolic Changes With Long-Acting Cabotegravir and Rilpivirine or Bictegravir/Emtricitabine/Tenofovir Alafenamide. JAIDS Journal of Acquired Immune Deficiency Syndromes. 98(4). 401–409. 4 indexed citations
2.
Vannappagari, Vani, Scott McCallister, Mark Bush, et al.. (2024). Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV. Infectious Diseases and Therapy. 13(7). 1391–1398. 3 indexed citations
3.
Andriole, Gerald L., David G. Bostwick, Leonard G. Gomella, et al.. (2014). Modeling and Analysis of Gleason Score 8-10 Prostate Cancers in the REDUCE Study. Urology. 84(2). 393–399. 3 indexed citations
4.
Fortuny, Clàudia, Dan Duiculescu, H Garges, et al.. (2013). Pharmacokinetics and 48-week Safety and Antiviral Activity of Fosamprenavir-containing Regimens in HIV-infected 2- to 18-year-old Children. The Pediatric Infectious Disease Journal. 33(1). 50–56. 8 indexed citations
5.
Cotton, Mark F., Noris Pavía-Ruz, H Garges, et al.. (2013). Pharmacokinetics, Safety and Antiviral Activity of Fosamprenavir/Ritonavir-containing Regimens in HIV-infected Children Aged 4 Weeks to 2 Years—48-week Study Data. The Pediatric Infectious Disease Journal. 33(1). 57–62. 6 indexed citations
6.
Smith, P. Brian, Daniel K. Benjamin, Reese H. Clark, et al.. (2009). Group B streptococcal meningitis: Cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Human Development. 85(10). S5–S7. 20 indexed citations
7.
Smith, P. Brian, H Garges, C. Michael Cotton, et al.. (2008). Meningitis in Preterm Neonates: Importance of Cerebrospinal Fluid Parameters. American Journal of Perinatology. 25(7). 421–426. 56 indexed citations
8.
Lalezari, Jacob, et al.. (2007). Preliminary safety and efficacy data of brecanavir, a novel HIV-1 protease inhibitor: 24 week data from study HPR10006. Journal of Antimicrobial Chemotherapy. 60(1). 170–174. 6 indexed citations
9.
Smith, P. Brian, C. Michael Cotten, H Garges, et al.. (2006). A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis. Journal of Perinatology. 26(2). 111–114. 21 indexed citations
10.
Garges, H, M. Anthony Moody, C. Michael Cotten, et al.. (2006). Neonatal Meningitis: What Is the Correlation Among Cerebrospinal Fluid Cultures, Blood Cultures, and Cerebrospinal Fluid Parameters?. PEDIATRICS. 117(4). 1094–1100. 218 indexed citations
11.
Benjamin, Daniel K., Elizabeth R. DeLong, C. Michael Cotten, H Garges, & Reese H. Clark. (2004). Postconception Age and Other Risk Factors Associated with Mortality Following Gram-negative Rod Bacteremia. Journal of Perinatology. 24(3). 169–174. 12 indexed citations
12.
Benjamin, Daniel K., Elizabeth R. DeLong, C. Michael Cotten, et al.. (2004). Mortality Following Blood Culture in Premature Infants: Increased with Gram-negative Bacteremia and Candidemia, but Not Gram-positive Bacteremia. Journal of Perinatology. 24(3). 175–180. 104 indexed citations
13.
Benjamin, Daniel K., H Garges, & William J. Steinbach. (2003). Candida bloodstream infection in neonates. Seminars in Perinatology. 27(5). 375–383. 48 indexed citations
14.
Garges, H & Kenneth Alexander. (2003). Pharmacology Review: Newer Antibiotics: Imipenem/cilastatin and Meropenem. NeoReviews. 4(12). 364e–368. 3 indexed citations
15.
Garges, H & Kenneth Alexander. (2003). Pharmacology Review. NeoReviews. 4(5). e128–e132.
16.
Benjamin, Daniel K., William C. Miller, H Garges, et al.. (2001). Bacteremia, Central Catheters, and Neonates: When to Pull the Line. PEDIATRICS. 107(6). 1272–1276. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026